Rapid COVID-19 Solutions Intrivo's focus on FDA-authorized at-home COVID-19 testing products like On/Go and the Test to Treat program presents opportunities to expand into providing complementary home testing and health monitoring solutions for public health initiatives and private healthcare providers.

Innovation and Technology Utilizing AI-powered mobile apps and advanced manufacturing tools, Intrivo is positioned as a leader in health tech innovation, opening avenues for selling advanced digital health integrations, data analytics services, and customized software solutions to enhance their product ecosystem.

Partnership Expansion Recent collaborations with companies like Gopuff highlight Intrivo’s interest in rapid distribution channels; there is potential to develop strategic partnerships with additional e-commerce and healthcare logistics firms to increase product reach and accessibility.

Growth in Market Reach With a strong emphasis on COVID-19 testing solutions, Intrivo has the opportunity to diversify into other health testing markets and personalized health management tools, targeting workplaces, educational institutions, and consumer health markets to drive revenue growth.

Financial and Product Diversification Although currently generating $1M-$10M in revenue, Intrivo’s innovative health technology focus provides avenues for investment in new product lines, including telehealth services, remote diagnostics, and data-driven health support systems, satisfying increasing demand for health tech solutions.